logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Karen V. MacDonald

University of Calgary
H指数:14
被引数:621

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A comprehensive approach to evaluating the clinical utility of genome sequencing in rare disease: A large prospective Canadian cohort

对基因组测序在罕见病中临床应用价值进行全面评估的方法：一项大型前瞻性加拿大队列研究

Genetics in Medicine
IF6.2
2026-01-100
OAAI
Salma Shickh; Katharine Fooks; Viji Venkataramanan; Meryl Acker; Karen V. MacDonald; Trevor A. Seeger; Meredith Gillespie; Taila Hartley; Kym M. Boycott; Francois Bernier; Deborah A. Marshall; Robin Z. Hayeems
Balancing safety and effectiveness: parent preferences for fecal microbiota transplant and established therapies in pediatric inflammatory bowel disease-results of a multicenter Canadian study

平衡安全性与有效性：父母对儿科炎症性肠病中粪便微生物移植与现有疗法的偏好——一项多中心加拿大研究的结果

CROHNS & COLITIS 360
IF0
2026-01-010
PRE
MacDonald, Karen, V; Pai, Nikhil; Burow, Carly; deBruyn, Jennifer C.; Huynh, Hien Q.; Otley, Anthony; Rozario, Sharlene; Marshall, Deborah A.
Effects of lyophilised faecal filtrate compared with lyophilised donor stool on Clostridioides difficile recurrence: a multicentre, randomised, double-blinded, non-inferiority trial

与冷冻干燥供体粪便相比，冷冻干燥粪便滤液对艰难梭菌复发的效果：一项多中心、随机、双盲、非劣效性试验

The Lancet Gastroenterology & Hepatology
IF0
2025-09-220
PRE
Dina Kao; Karen Wong; Christine Lee; Theodor Steiner; Rose Franz; Chelsea McDougall; Marisela Silva; Thomas S B Schmidt; Jens Walter; Raimar Loebenberg; Tanya M Monaghan; Ryland T Giebelhaus; James J Harynuk; Huiping Xu; Maryna Yaskina; Karen V MacDonald; Deborah A Marshall; Thomas Louie
Strong preferences or simplifying heuristics? Using internal-validity tests and latent-class analysis to better understand stated preference survey results. A case example in health preferences research.

偏好强烈还是简化启发式？利用内部效度检验和潜类别分析来更好地理解陈述偏好调查结果。健康偏好研究的一个案例示例。

Value in Health
IF6
2025-07-070
PREAI
Karen V. MacDonald; Juan Marcos Gonzalez Sepulveda; F. Reed Johnson; Deborah A. Marshall
Developing a Framework of Cost Elements of Socioeconomic Burden of Rare Disease: A Scoping Review

开发罕见病社会经济负担成本要素框架：一项范围综述

Pharmacoeconomics
IF4.6
2023-04-070
PRE
Gillian R. Currie; Brittany Gerber; Diane Lorenzetti; Karen MacDonald; Susanne M. Benseler; Francois P. Bernier; Kym M. Boycott; K. Vanessa Carias; Bettina Hamelin; Robin Z. Hayeems; Claire LeBlanc; Marinka Twilt; Gijs van Rooijen; Durhane Wong-Rieger; Rae S. M. Yeung; Deborah A. Marshall

研究方向

暂未获取到该数据
D
Deborah A. Marshall
H 指数:63论文数:574被引数:2.1万
K
Kym M. Boycott
H 指数:77论文数:442被引数:2.1万
F
François P. Bernier
H 指数:56论文数:238被引数:1.0万
J
Juan Marcos González
H 指数:26论文数:255被引数:3,601
G
Gillian Currie
H 指数:23论文数:112被引数:2,182
T
Taila Hartley
H 指数:34论文数:112被引数:4,374
B
Brenda McInnes
H 指数:11论文数:29被引数:597
M
Michael P. Douglas
H 指数:27论文数:105被引数:3,003
R
Robin Z. Hayeems
H 指数:33论文数:201被引数:4,007
F
F. Reed Johnson
H 指数:51论文数:275被引数:1.3万